Management of Endometriosis in Teenagers

In: ISGE Series · 2020 · pp. 51–63 · doi:10.1007/978-3-030-57866-4_6 · W3111915357
book-chapter OA: closed CC0 ⤵ 2 in-corpus citations
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06+body, 2026-06-17

Endometriosis in adolescents presents diagnostic and treatment challenges, with severe dysmenorrhea occurring in 50-80% and chronic pelvic pain associated with endometriosis in 45-70% of cases.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-17 · read from full text

This chapter reviews the management of endometriosis in adolescents, focusing on diagnostic challenges, variable clinical presentation, and considerations for treatment selection, while situating adolescent dysmenorrhea and chronic pelvic pain within reported prevalence estimates. It notes that dysmenorrhea affects 50–80% of adolescents and that pelvic abnormalities such as endometriosis or uterine anomalies are found in about 10% of adolescents with severe dysmenorrhea; incidence of endometriosis has been reported at 45–70% among adolescents with chronic pelvic pain. The chapter’s main limitation is that it is an opinion/chapter-style synthesis rather than a single primary study, and the figures it cites reflect reported ranges rather than uniform estimates. This paper is centrally about endometriosis in teenagers — it specifically focuses on how adolescent endometriosis presents and how it is managed.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 8,692 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Endometriosis in adolescents needs unique considerations for treatment approaches, as it presents particular challenges in terms of diagnosis, variable presentation and symptoms, and choice of treatment [1]. Dysmenorrhea is the most common gynecologic issue among adolescents, occurring in 50–80% of these and causing limitation in sports and activities, poor academic performance, and long duration of resting (Fig. 6.1). In about 10% of adolescents with severe dysmenorrhea symptoms, pelvic abnormalities such as endometriosis or uterine anomalies may be found and the incidence of endometriosis has been reported between 45% and 70% in adolescents with chronic pelvic pain (CPP) [2]. Access this chapter Tax calculation will be finalised at checkout Purchases are for personal use only Similar content being viewed by others

References

Benagiano G, Guo SW, Puttemans P, Gordts S, Brosens I. Progress in the diagnosis and management of adolescent endometriosis: an opinion. Reprod BioMed Online. 2018;36:102–14. Dun EC, Kho KA, Morozov VV, Kearney S, Zurawin JL, Nezhat CH. Endometriosis in adolescents. JSLS. 2015;19:e2015.00019. Sieberg CB, Lunde CE, Borsook D. Endometriosis and pain in the adolescent striking early to limit suffering: a narrative review. Neurosci Biobehav Rev. 2020;108:866–76. Vercellini P, Buggio L, Frattaruolo MP, Borghi A, Dridi D, Somigliana E. Medical treatment of endometriosis-related pain. Best Pract Res Clin Obstet Gynaecol. 2018;51:68–91. Johnson NP, Hummelshoj L, Adamson GD, et al. World endometriosis society consensus on the classification of endometriosis. Hum Reprod. 2017;32:315–24. Seyhan A, Ata B, Uncu G. The impact of endometriosis and its treatment on ovarian reserve. Semin Reprod Med. 2015;33:422–8. Liu X, Long Q, Guo SW. Surgical history and the risk of endometriosis: a hospital-based case-control study. Reprod Sci. 2016;23:1217–24. Sibiude J, Santulli P, Marcellin L, Borghese B, Dousset B, Chapron C. 2014. Association of history of surgery for endometriosis with severity of deeply infiltrating endometriosis. Obstet. Gynecologie. 2014;124:709–917. Zhang Q, Duan J, Olson M, Fazleabas A, Guo SW. Cellular changes consistent with epithelial-mesenchymaltransition and fibroblast-to-myofibroblast transdifferentiation in the progression of experimental endometriosis in baboons. Reprod Sci. 2016;23:1409–21. Unger CA, Laufer MR. Progression of endometriosis in nonmedically managed adolescents: a case series. J Pediatr Adolesc Gynecol. 2011;24:e21–3. Stuparich MA, Donnellan NM, Sanfilippo JS. Endometriosis in the adolescent patient. Semin Reprod Med. 2017;35:102–9. Steenberg CK, Tanbo TG, Qvigstad E. Endometriosis in adolescence: predictive markers and management. Acta Obstet Gynecol Scand. 2013;92:491–5. Shim JY, Laufer MR. Adolescent endometriosis: an update. J Pediatr Adolesc Gynecol. 2020;33(2):112–9. Kaser DJ, Laufer MR. Norethindrone acetate for hormonal suppression of adolescent endometriosis-associated pain. J Pediatr Adolesc Gynecol. 2011;24:e49. Yoost J, LaJoie AS, Hertweck P, et al. Use of the levonoresgetrel intrauterine system in adolescents with endometriosis. J Pediatr Adolesc Gynecol. 2013;26:120. Schindler AE, Henkel A, Moore C, Oettel M. Effect and safety of high-dose dienogest (20 mg/day) in the treatment of women with endometriosis. Arch Gynecol Obstet. 2010;282:507–14. Ebert AD, Dong L, Merz M, et al. Dienogest 2 mg daily in the treatment of adolescents with clinically suspected endometriosis: the VISanne study to assess safety in ADOlescents. J Pediatr Adolesc Gynecol. 2017;30:560–7. Sadler Gallagher J, Feldman HA, Stokes NA, et al. The effects of gonadotropin-releasing hormone agonist combined with add-back therapy on quality of life for adolescents with endometriosis: a randomized controlled trial. J Pediatr Adolesc Gynecol. 2017;30:215. Taylor HS, Giudice LC, Lessey BA, et al. Treatment of endometriosis-associated pain with Elagolix, an oral GnRH antagonist. N Engl J Med. 2017;377:28. Tosti C, Biscione A, Morgante G, et al. Hormonal therapy for endometriosis: from molecular research to bedside. Eur J Obstet Gynecol Reprod Biol. 2017;209:61–6. Weng Q, Ding Z, Lv X, et al. Chinese medicinal plants for advanced endometriosis after conservative surgery: a prospective, multicenter, controlled trial. Int J Clin Exp Med. 2015;8:11307–11. Pinho-Ribeiro FA, Verri WA Jr, Chiu IM. Nociceptor sensory neuron-immune interactions in pain and inflammation. Trends Immunol. 2017;38:5–19. Symons LK, Miller JE, Kay VR, et al. The immunopathophysiology of endometriosis. Trends Mol Med. 2018;24:748–62. Gómez R, Abad A, Delgado F, Tamarit S, Simón C, Pellicer A. Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyper-prolactinemia. Fertil Steril. 2011;95:882–8. Li X, Liu X, Guo SW. Histone deacetylase inhibitors as therapeutics for endometriosis. Expert Rev Obstet Gynecol. 2014;7:451–66. Harel Z. Dysmenorrhea in adolescents and young adults: etiology and management. J Pediatr Adolesc Gynecol. 2006;19:363–71. Mama ST. Advances in the management of endometriosis in the adolescent. Curr Opin Obstet Gynecol. 2018;30:326–30. Smorgick N, As-Sanie S, Marsh CA, Smith YR, Quint EH. Advanced stage endometriosis in adolescents and young women. J Pediatr Adolesc Gynecol. 2014;27:320–3. Matalliotakis M, Goulielmos GN, Matalliotaki C, et al. Endometriosis in adolescents and young girls: report of a series of 85 cases. J Pediatr Adolesc Gynecol. 2017;30:568. Audebert A, Lecointre L, Afors K, Koch A, Wattiez A, Akladios C. Adolescent endometriosis: report of a series of 55 cases with a focus on clinical presentation and long-term issues. J Minim Invasive Gynecol. 2015;22:834–40. Sanfilippo JS, Mansuria SM, Donnellan NM. Surgical problems in the pediatric patient. In: Bieber EJ, Sanfilippo JS, Horowitz IR, Shafi MI, editors. Clinical gynecology. 2nd ed. Cambridge, UK: Cambridge University Press; 2015. p. 576–8. Hogg S, Vyas S. Endometriosis update. Obstet Gynaec Repro Med. 2017;28:61–9. Healey M, Ang C, Cheng C. Surgical treatment of endometriosis: a prospective randomized double-blinded trial comparing excision and ablation. Fertil Steril. 2010;94:2536e40. Laufer MR, Einarsson JI. Surgical management of superficial peritoneal adolescent endometriosis. J Pediatr Adolesc Gynecol. 2019;32:339. Saridogan E. Adolescent endometriosis. Eur J Obstet Gynecol Reprod Biol. 2017;209:46–9. Yeung J, Sinervo K, Winer W, et al. Complete laparoscopic excision of endometriosis in teenagers: is postoperative hormonal suppression necessary? Fertil Steril. 2011;95:1909–12. Rimbach S, Ulrich U, Schweppe KW. Surgical therapy of endometriosis: challenges and controversies. Geburtshilfe Frauenheilkd. 2013;73:918–23. Roman JD. Adolescent endometriosis in the Waikato region of New Zealand–a comparative cohort study with a mean follow-up time of 2.6 years. Aust N Z J Obstet Gynaecol. 2010;50:179–83. Tandoi I, Somigliana E, Riparini J, Ronzoni S, Vigano P, Candiani M. High rate of endometriosis recurrence in young women. J Pediatr Adolesc Gynecol. 2011;24:376–9. Yang Y, Wang Y, Yang J, Wang S, Lang J. Adolescent endometriosis in China: a retrospective analysis of 63 cases. J Pediatr Adolesc Gynecol. 2012;25:295–9. Shakiba K, Bena JF, McGill KM, Minger J, Falcone T. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstet Gynecol. 2008;111:1285–92. Wattier JM. Conventional analgesics and non-pharmacological multidisciplinary therapeutic treatment in endometriosis: CNGOF-HAS endometriosis guidelines. Gynecol Obstet Fertil Senol. 2018;46:248–55. Mira TAA, Buen MM, Borges MG, et al. Systematic review and meta-analysis of complementary treatments for women with symptomatic endometriosis. Int J Gynaecol Obstet. 2018;143:2. Conflict of Interest None. Financial Support None. Author information Authors and Affiliations Corresponding author Editor information Editors and Affiliations Rights and permissions Copyright information © 2021 International Society of Gynecological Endocrinology About this chapter Cite this chapter Troìa, L., Biscione, A., Colombi, I., Luisi, S. (2021). Management of Endometriosis in Teenagers. In: Genazzani, A.R., Nisolle, M., Petraglia, F., Taylor, R.N. (eds) Endometriosis Pathogenesis, Clinical Impact and Management. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-030-57866-4_6 Download citation DOI: https://doi.org/10.1007/978-3-030-57866-4_6 Published: Publisher Name: Springer, Cham Print ISBN: 978-3-030-57865-7 Online ISBN: 978-3-030-57866-4 eBook Packages: MedicineMedicine (R0)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (46)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-07-31T06:42:51.797318+00:00
License: CC0 · commercial use OK